Serum interleukin-35 and pentraxin-3 levels 
in patients with mild acute pancreatitis

Evrim Aksoy; Ferdane Sapmaz; Özlem Doğan; Zeynep Göktaş; Metin Uzman; Yaşar Nazlıgül

doi:10.5114/pg.2019.83425

eISSN: 1897-4317
ISSN: 1895-5770

Gastroenterology Review/Przegląd Gastroenterologiczny

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

1/2019
vol. 14

Send email

Copy url:

abstract:

Original paper

Serum interleukin-35 and pentraxin-3 levels in patients with mild acute pancreatitis

Evrim Kahramanoğlu Aksoy

,

Ferdane Pirinççi Sapmaz

,

Özlem Doğan

,

Zeynep Göktaş

,

Metin Uzman

,

Yaşar Nazlıgül

Gastroenterology Rev 2019; 14 (1): 48–54

DOI: https://doi.org/10.5114/pg.2019.83425

Online publish date: 2019/03/12

View full text Get citation

PlumX metrics:

Introduction
Interleukin-35 (IL-35) is a newly defined potent anti-inflammatory cytokine that is predominantly produced by regulatory T cells, and pentraxin-3 belongs to the acute-phase proteins.

Aim
To measure the serum IL-35 and pentraxin-3 levels in the early phase of mild acute pancreatitis (AP).

Material and methods
Eighty-three patients with mild AP and 30 healthy controls were included in the study. The serum levels of IL-35 and pentraxin-3 were measured by enzyme-linked immunosorbent assay upon admission and at the 48th hour after diagnosis.

Results
The mean value of serum IL-35 levels in patients with mild acute pancreatitis at admission was 5.91 ng/ml (4.21–7.90) and was significantly lower than those in healthy controls (25.53 ng/ml (12.79–54.73, p < 0.001)) and 48-hour value were (6.79 ng/ml (4.42–9.62) (p = 0.015)). The mean value of serum pentraxin-3 levels in patients at the time of admission was 6.75 ng/ml (4.42–9.62) and there was no significant difference from healthy controls, at 7.64 ng/ml (6.58–8.62, p > 0.05). Also there was no significant difference between the mean value at admission and the mean value at 48-hour, 6.75 ng/ml (4.74–9.06, p > 0.05).

Conclusions
Interleukin-35 can be used in diagnosis and follow-up in patients with mild AP.

keywords:

Serum interleukin-35 and pentraxin-3 levels in patients with mild acute pancreatitis

Evrim Kahramanoğlu Aksoy , Ferdane Pirinççi Sapmaz , Özlem Doğan , Zeynep Göktaş , Metin Uzman , Yaşar Nazlıgül

mild acute pancreatitis, interleukin-35, pentraxin-3

Evrim Kahramanoğlu Aksoy

,

Ferdane Pirinççi Sapmaz

,

Özlem Doğan

,

Zeynep Göktaş

,

Metin Uzman

,

Yaşar Nazlıgül